Skip to main content
. 2021 May 26;61(5):e14–e25. doi: 10.1016/j.japh.2021.05.006

Appendix 2 Methodological quality of studies included

Joanna Briggs Institute Checklist McKeigue et al.421 Taher et al.117 Poblador-Plou et al.216 McQueenie et al. 202018 Gavin et al 202019 De Smet et al.322 Sun et al. 202020
Case Control Studies£
  • 1.

    Were the groups comparable other than the presence of disease in cases or the absence of disease in controls?

Yes
  • 2.

    Were cases and controls matched appropriately?

Yes
  • 3.

    Were the same criteria used for identification of cases and controls?

No
  • 4.

    Was exposure measured in a standard, valid and reliable way?

Yes
  • 5.

    Was exposure measured in the same way for cases and controls?

Yes
  • 6.

    Were confounding factors identified?

Unclear
  • 7.

    Were strategies to deal with confounding factors stated?

Yes
  • 8.

    Were outcomes assessed in a standard, valid, and reliable way for cases and controls?

Yes
  • 9.

    Was the exposure period of interest long enough to be meaningful?

Yes
  • 10.

    Was appropriate statistical analysis used?

Yes
Total Score 8
Cohort Studies#
  • 1.

    Were the 2 groups similar and recruited from the same population?

Yes Yes Yes
  • 2.

    Were the exposures measured similarly to assign people

Yes Yes Yes
  • 3.

    to both exposed and unexposed groups?

No No Yes
  • 4.

    Was the exposure measured in a valid and reliable way?

Yes Yes Yes
  • 5.

    Were confounding factors identified?

No No Yes
  • 6.

    Were strategies to deal with confounding factors stated?

No No Yes
  • 7.

    Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?

No No No
  • 8.

    Were the outcomes measured in a valid and reliable way?

Yes Yes Yes
  • 9.

    Was the follow-up time reported and sufficient to be long enough for outcomes to occur?

No Yes Yes
  • 10.

    Was follow-up complete, and if not, were the reasons for loss to follow-up described and explored?

Yes Yes Yes
  • 11.

    Were strategies to address incomplete follow-up utilized?

No Yes Yes
  • 12.

    Was appropriate statistical analysis used?

Yes Yes Yes
Total Score 6 8 11
Prevalence Dataπ
  • 1.

    Was the sample frame appropriate to address the target population?

Yes Yes Yes
  • 2.

    Were study participants sampled in an appropriate way?

Yes Yes Yes
  • 3.

    Was the sample size adequate?

Yes Yes Yes
  • 4.

    Were the study subjects and the setting described in detail?

Yes No Yes
  • 5.

    Was the data analysis conducted with sufficient coverage of the identified sample?

Yes Yes Yes
  • 6.

    Were valid methods used for the identification of the condition?

Yes Yes Yes
  • 7.

    Was the condition measured in a standard, reliable way for all participants?

Yes Yes Yes
  • 8.

    Was there appropriate statistical analysis?

Yes Yes Yes
  • 9.

    Was the response rate adequate, and if not, was the low response rate managed appropriately?

Yes Yes Yes
Total Score 9 8 9
£

Maximum Attainable Score for Case Control Studies is 10.

#

Maximum Attainable Score for cohort Studies is 12.

π

Maximum Attainable Score for prevalence Studies is 9.